Literature DB >> 15218236

Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region.

N P Jarufe1, C Coldham, A D Mayer, D F Mirza, J A C Buckels, S R Bramhall.   

Abstract

AIMS: To present the surgical experience in a regional unit, analysing the post-operative outcome, and determining risk factors for survival after pancreaticoduodenectomy for periampullary and pancreatic head carcinoma.
METHODS: Data were collected on 251 patients with pancreatic head adenocarcinoma (133), ampullary carcinomas (88) and distal common bile duct (30), between 1987 and 2002. Survival was calculated using the Kaplan-Meier method. Clinical, surgical and histopathological records were examined by univariate and multivariate analysis to identify the independent prognostic predictors of survival.
RESULTS: Median actuarial survival for carcinoma of the pancreatic head, ampulla and distal bile duct were 13.4, 35.5 and 16 months, respectively; p < 0.0001. On univariate analysis for the whole series, the age < or =60, tumour of the head of the pancreas, lymph node positive, resection margin R1, poorly differentiated tumours, and portal vein invasion significantly decreased survival. On multivariate analysis, poor tumour differentiation, surgical margin, lymph node metastases, and age independently influence survival. Mortality and morbidity were 4.8 and 29.9%, respectively.
CONCLUSIONS: Pancreaticoduodenectomy for pancreatic and periampullary tumours is the only therapy that may cure patients and can be performed safely in centres with significant experience. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15218236     DOI: 10.1159/000079346

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  23 in total

1.  Factors affecting survival in patients who underwent pancreaticoduodenectomy for periampullary cancers.

Authors:  Temel Deniz Şeren; Koray Topgül; Bülent Koca; Kenan Erzurumlu
Journal:  Ulus Cerrahi Derg       Date:  2015-06-01

Review 2.  Pathology handling of pancreatoduodenectomy specimens: Approaches and controversies.

Authors:  María Del Carmen Gómez-Mateo; Luis Sabater-Ortí; Antonio Ferrández-Izquierdo
Journal:  World J Gastrointest Oncol       Date:  2014-09-15

Review 3.  A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma.

Authors:  James R Butler; Syed A Ahmad; Matthew H Katz; Jessica L Cioffi; Nicholas J Zyromski
Journal:  HPB (Oxford)       Date:  2016-02-01       Impact factor: 3.647

4.  Peripancreatic soft tissue involvement: independent outcome predictor in patients with resected pancreatic adenocarcinoma.

Authors:  Alireza Hamidian Jahromi; Gazi B Zibari; Elnaz Jafarimehr; Quyen Chu; Gregory P Wellman; Runhua Shi; Lester W Johnson; Hosein Shokouh-Amiri
Journal:  Int Surg       Date:  2014 Jan-Feb

Review 5.  Management of borderline and locally advanced pancreatic cancer: where do we stand?

Authors:  Jin He; Andrew J Page; Matthew Weiss; Christopher L Wolfgang; Joseph M Herman; Timothy M Pawlik
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

6.  Pancreaticoduodenectomy in a Latin American country: the transition to a high-volume center.

Authors:  Carlos Chan; Bernardo Franssen; Alethia Rubio; Luis Uscanga
Journal:  J Gastrointest Surg       Date:  2007-09-01       Impact factor: 3.452

7.  Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival.

Authors:  Biku J John; Prashant Naik; Alastair Ironside; Brian R Davidson; Guiseppe Fusai; Roopinder Gillmore; Jennifer Watkins; Sakhawat H Rahman
Journal:  HPB (Oxford)       Date:  2013-01-14       Impact factor: 3.647

8.  Pylorus-preserving pancreaticoduodenectomy versus conventional pancreaticoduodenectomy for pancreatic adenocarcinoma.

Authors:  Masaji Tani; Manabu Kawai; Seiko Hirono; Shinomi Ina; Motoki Miyazawa; Yoichi Fujita; Kazuhisa Uchiyama; Hiroki Yamaue
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

9.  2564 resected periampullary adenocarcinomas at a single institution: trends over three decades.

Authors:  Jin He; Nita Ahuja; Martin A Makary; John L Cameron; Frederic E Eckhauser; Michael A Choti; Ralph H Hruban; Timothy M Pawlik; Christopher L Wolfgang
Journal:  HPB (Oxford)       Date:  2013-03-08       Impact factor: 3.647

10.  The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials.

Authors:  J Gaedcke; B Gunawan; M Grade; R Szöke; T Liersch; H Becker; B M Ghadimi
Journal:  Langenbecks Arch Surg       Date:  2009-05-06       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.